JPRN-UMIN000014239已完成2 期
Randomized phase II study of rikkunshito on chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy for lung cancer (HOT1402) - Phase II study of rikkunshito on CINV in patients receiving HEC for lung cancer
Hokkaido Lung Cancer Clinical Study Group0 个研究点目标入组 58 人开始时间: 2014年6月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Drug allergy unfit for the study 2)Active infectious diseases 3)Severe complications (severe cardiac diseases, cerebrovascular diseases, active peptic ulcer, poorly controlled diabetes mellitus, clinically problematic, psycho-neurologic diseases) 4)Symptomatic brain metastasis 5)Active concomitant malignancy 6)Women who is lactating or pregnant or man who hope the pregnancy of the partner 7)Previous Rikkunshito therapy 8)Ineligible judgment by the physician
研究者
相似试验
招募中
2 期
Randomized phase II study of rikkunshito on chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy for lung cancer (HOT1403)ung CancerJPRN-UMIN000014240Hokkaido Lung Cancer Clinical Study Group62
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (modified MAID therapy) for high grade bone and soft tissue sarcomas.High-grade bone and soft tissue sarcomasJPRN-UMIN000015113Tokyo Metropolitan Komagome Hospital10
尚未招募
不适用
Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (GD therapy) for high-grade soft tissue sarcomas.High-grade soft tissue sarcomasJPRN-UMIN000015120Tokyo Metropolitan Komagome Hospital10
已完成
不适用
The study for the efficacy of rikkunshito on anorexia in the patients who underwent laparoscopy assisted gastrectomy and open gastrectomyGastric cancer patient who underwent laparoscopy assisted gastrectomy or open gastrectomyJPRN-UMIN000008564Department of Gastroenterological and General Surgery St.Marianna University School of Medicine Hospital60
进行中（未招募）
1 期
A Phase 2 Study of Ruxolitinib in Combination With Pemetrexed/Cisplatin and for Treatment of Subjects With Advanced Lung Canceronsquamous NSCLC that is Stage IIIB, Stage IV, or recurrentMedDRA version: 18.0Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10029515Term: Non-small cell lung cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001436-10-PTIncyte Corporation156